vitafood-160
News
U.S. FDA approves SpringWorks Therapeutics’ GOMEKLI for patients with NF1-PN
The U.S. Food and Drug Administration (FDA) has approved SpringWorks Therapeutics' GOMEKLI (mirdametinib), SpringWorks’ MEK inhibitor, for the treatment of adult and pediatric patients...
U.S. FDA approves EMBLAVEO for adults with complicated intra-abdominal infections
The U.S. Food and Drug Administration (FDA) has approved AbbVie's EMBLAVEO (aztreonam and avibactam), as the first and only fixed-dose, intravenous, monobactam/β-lactamase inhibitor combination...
Bain Capital to acquire Mitsubishi Tanabe Pharma Corporation
Bain Capital, a global private investment firm, has signed a definitive agreement to acquire Mitsubishi Tanabe Pharma Corporation (Tanabe Pharma or MTPC) in a...
